Mapping of health technology assessment in China: a comparative study between 2016 and 2021.

ABSTRACT:

Background

Health Technology Assessment (HTA) in China has recently expanded from purely academic research to include policy or decision-oriented practice, especially after HTA evidence was used to update the National Reimbursement Drug List for the first time in 2017. This study aims to identify the progress and challenges of HTA development from 2016 to 2021 and inform policies and decisions to promote further HTA development in China.

Methods

We conducted a cross-sectional web-based survey with policy makers, researchers and industry-providers in China in 2016 and 2021 respectively. The 'Mapping of HTA Instrument', was utilized to assess the HTA development across eight domains: Institutionalization, Identification, Priority setting, Assessment, Appraisal, Reporting, Diss

SUBMITTER: Liu S 

PROVIDER: S-EPMC10790493 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature